Hyperpolarized Imaging for New Treatments

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cystic Fibrosis
Interventions
DRUG

Initiation of CFTR Modulator

Inhaled contrast for MRI occurring at each 4 visits.

Trial Locations (4)

22908

University of Virginia School of Medicine, Charlottesville

53792

University of Wisconsin, Madison

45229-3019

Cincinnati Children's Hospital Medical Center, Cincinnati

M5G 1X8

The Hospital for Sick Kids, Toronto

All Listed Sponsors
collaborator

University of Virginia

OTHER

collaborator

University of Wisconsin, Madison

OTHER

collaborator

The Hospital for Sick Children

OTHER

lead

Children's Hospital Medical Center, Cincinnati

OTHER